| Literature DB >> 30577610 |
Tunde Jurikova1, Sona Skrovankova2, Jiri Mlcek3, Stefan Balla4, Lukas Snopek5.
Abstract
Lesser known fruits or underutilized fruit species are recently of great research interest due to the presence of phytochemicals that manifest many biological effects. European cranberry, Vaccinium oxycoccos fruit, as an important representative of this group, is a valuable source of antioxidants and other biologically active substances, similar to American cranberry (V. macrocarpon) which is well known and studied. European cranberry fruit is rich especially in polyphenolic compounds anthocyanins (12.4⁻207.3 mg/100 g fw), proanthocyanins (1.5⁻5.3 mg/100 g fw), and flavonols, especially quercetin (0.52⁻15.4 mg/100 g fw), which mostly contribute to the antioxidant activity of the fruit. Small cranberry is also important due to its various biological effects such as urinary tract protection (proanthocyanidins), antibacterial and antifungal properties (quercetin, proanthocyanidins, anthocyanins), cardioprotective (proanthocyanidins) and anticancer activities (proanthocyanidins), and utilization in food (juice drinks, jams, jellies, sauces, additive to meat products) and pharmacological industries, and in folk medicine.Entities:
Keywords: Vaccinium oxycoccos; antioxidant effect; biological activities; cranberry; polyphenols
Mesh:
Substances:
Year: 2018 PMID: 30577610 PMCID: PMC6337168 DOI: 10.3390/molecules24010024
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
The overview of major phenolic compounds in European cranberry.
| Phenolic Compounds | Content | References | |
|---|---|---|---|
| Phenolic acids | Benzoic acid | 99.6–214.6 | Stobnicka and Gniewosz [ |
| 2.0–78.0 | Stobnicka and Gniewosz [ | ||
| Chlorogenic acid | 61.0–96.3 | Stobnicka and Gniewosz [ | |
| Caffeic acid | 0.7–1.4 | Stobnicka and Gniewosz [ | |
| Ferrulic acid | 68.1% (% of all phenolic acids) | Häkkinen et al. [ | |
| Anthocyanins | Anthocyanins | 12.4–207.3 | Kivimäki et al. [ |
| Cyanidin-3-galactoside | 13.1–26.8% (mean 19.8% of all anthocyanins) | Česonienė et al. [ | |
| Cyanidin-3-glucoside | 0.09–13.4% (mean 3.4% of all anthocyanins) | Česonienė et al. [ | |
| Cyanidin-3-arabinoside | 16.5–40.5% (mean 21.7% of all anthocyanins) | Česonienė et al. [ | |
| Peonidin-3-galactoside | 5.9–42.8% (mean 30% of all anthocyanins) | Česonienė et al. [ | |
| Peonidin-3-glucoside | 1.4–23.3% (mean 7.4% of all anthocyanins) | Česonienė et al. [ | |
| Peonidin-3-arabinoside | 3.4–28.5% (mean 17.4% of all anthocyanins) | Česonienė et al. [ | |
| Flavonoids | Quercetin | 0.52–15.4 | Ehala et al. [ |
| Myricetin | 8.4–11.2 | Stobnicka and Gniewosz [ | |
| Epicatechin | 3.1–6.3 | Stobnicka and Gniewosz [ | |
| Proanthocyanins | 1.5–5.3 | Kivimäki et al. [ | |
Comparison of the polyphenolic spectrum of V. oxycoccos and V. macrocarpon fruit and pomace ethanol extracts [11,32].
| Phenolic Compounds | Content (mg/100 g fw) | ||
|---|---|---|---|
| Benzoic acid | 214.6 | 115.0 | 256.9 |
| 77.0 | 175.0 | 184.3 | |
| Chlorogenic acid | 96.3 | 408.7 | 656.9 |
| Caffeic acid | 1.4 | 36.5 | 31.2 |
|
| 389.5 | 777.0 | 1173.8 |
| Quercetin | 15.4 | 25.2 | 11.5 |
| Epicatechin | 6.3 | 5.7 | 12 |
| Isorhamnetin | 3.5 | 1.5 | 0.9 |
|
| 36.3 | 81.5 | 42.9 |
The major bioactive compounds of European cranberry fruit and their effect.
| Bioactive Compounds | Biological Effect | References |
|---|---|---|
| Quercetin | anti-inflammatory | Mlcek et al. [ |
| antibacterial and antifungal | Cushnie et al. [ | |
| Proanthocyanidins | anticancer | Masoudi et al. [ |
| antimicrobial | Neto et al. [ | |
| urinary tract protection | Jungfer et al. [ | |
| cardioprotective | Kalt et al. [ | |
| Resveratrol | antibacterial, antifungal | Stobnicka et al. [ |
| Anthocyanins | antibacterial | Toivanen et al. [ |
| cardioprotective | Kalt et al. [ |
Summarization of the evidence of European cranberry biological activities.
| Effect | Studied Models | Mechanism of Action | References |
|---|---|---|---|
|
| agar well diffusion method; human epithelial cells | antiadhesion activity (blocking bacterial adhesion) against | Toivanen et al. [ |
| in vitro studies (minced pork meat) | inhibition of the growth of | Stobnicka and Gniewosz [ | |
| agar well diffusion method | inhibitory effect on hemagglutination of | Česonienė et al. [ | |
| in vitro studies (sugar reduced fruit spreads) | inhibition of growth of | Ermis et al. [ | |
| diffusion methods; human bronchial cells (Calu-3) | Antibacterial inhibitory activity against | Rauha et al. [ | |
|
| in vitro studies | effect of type-A proanthocyanidins; inhibition of the adherence of | Davidson et al. [ |
| women participants; | prevention of UTI, blocking of fimbrial adhesion of causative bacterium | Kontiokari et al. [ | |
|
| in vitro model, rats fed with juice | vascular anti–inflammatory properties, inhibition of LPS (Lipopolysaccharide-) induced NO (nitric oxide) production, inhibition LPS-induced IL-6, IL-1β and TNF-α production | Kylli et al. [ |
| Spontaneously hypertensive rats (SHR) model | normalization of the impaired endothelium-dependent relaxation of mesenteric arteries, activity of endothelium-derived hyperpolarizing factor | Kivimäki et al. [ | |
|
| in vitro model (human oral, breast, colon tumor cells) | inhibition of stages of carcinogenesis, stimulation of the apoptosis of cancer cells | Seeram et al. [ |
| human prostate cancer cells | inhibition of specific temporal NMP (1-Methyl-2-pyrrolidone) regulators | Seeram et al. [ |